Literature DB >> 9033661

Retinoid-interferon therapy of solid tumors.

S M Lippman1, R Lotan, U Schleuniger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9033661     DOI： 10.1002/(sici)1097-0215(19970207)70:4<481::aid-ijc20>3.0.co;2-h

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  4 in total

1.  All-trans-retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity.

Authors:  K L DeCicco; J D Youngdahl; A C Ross
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

2.  Opposing cytokine-specific effects of all trans-retinoic acid on the activation and expression of signal transducer and activator of transcription (STAT)-1 in THP-1 cells.

Authors:  Qiuyan Chen; Yifan Ma; A Catharine Ross
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

3.  Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL.

Authors:  Nicole Clarke; Ana M Jimenez-Lara; Emilie Voltz; Hinrich Gronemeyer
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

4.  Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.

Authors:  Qiuyan Chen; A Catharine Ross
Journal:  Exp Cell Res       Date:  2004-07-01       Impact factor: 3.905
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.